401k Plan data: UNIVERSITY PHARMACEUTICALS OF M.D. 401(K) PLAN plan

UNIVERSITY PHARMACEUTICALS OF M.D. 401(K) PLAN 401k Plan overview

Plan Name	UNIVERSITY PHARMACEUTICALS OF M.D. 401(K) PLAN
Plan identification number	001

UNIVERSITY PHARMACEUTICALS OF M.D. 401(K) PLAN Benefits

401k Plan Type

Defined Contribution Pension

Plan Features/Benefits

Profit-sharing
ERISA section 404(c) Plan - This plan, or any part of it is intended to meet the conditions of 29 CFR 2550.404c-1.
Total participant-directed account plan - Participants have the opportunity to direct the investment of all the assets allocated to their individual accounts, regardless of whether 29 CFR 2550.404c-1 is intended to be met.
Code section 401(k) feature - A cash or deferred arrangement described in Code section 401(k) that is part of a qualified defined contribution plan that provides for an election by employees to defer part of their compensation or receive these amounts in cash.
Code section 401(m) arrangement - Employee contributions are allocated to separate accounts under the plan or employer contributions are based, in whole or in part, on employee deferrals or contribtions to the plan. Not applicable if plan is 401(k) plan with only QNECs and/or QMACs. Also not applicable if Code section 403(b)(1), 403(b)(7) or 408 arrangements/accounts/annuities.
Total or partial participant-directed account plan - plan uses default investment account for participants who fail to direct assets in their account.
Master plan - A pension plan that is made available by a sponsor for adoption by employers; that is the subject of a favorable opinion letter; and for which a single funding medium (for example, a trust or custodial account) is established for the joint use of all adopting employers.
Plan sponsor(s) received services of leased employees, as defined in Code section 414(n), during the plan year.
Plan sponsor(s) is (are) a member(s) of a controlled group (Code sections 414(b), (c), or (m)).

401k Sponsoring company profile

GREGORY PHARMACEUTICAL HOLDINGS, INC has sponsored the creation of one or more 401k plans.

Company Name: GREGORY PHARMACEUTICAL HOLDINGS, INC

Employer identification number (EIN): 522043017

NAIC Classification: 541700

Form 5500 Filing Information

Submission information for form 5500 for 401k plan UNIVERSITY PHARMACEUTICALS OF M.D. 401(K) PLAN

Plan id# Filing Submission Date Name of Administrator Date Administrator Signed Name of Company Sponsor Date Sponsor Signed
001 2022-01-01
001 2021-01-01
001 2020-01-01
001 2019-01-01
001 2018-01-01
001 2018-01-01
001 2017-01-01 JOHN C. BOWLES JOHN C. BOWLES 2018-10-10
001 2017-01-01 JOHN C. BOWLES JOHN C. BOWLES 2018-07-12
001 2017-01-01 JOHN BOWLES
001 2017-01-01
001 2016-01-01 GREGORY TEBEAU
001 2016-01-01 JOHN C. BOWLES JOHN C.BOWLES 2018-07-12
001 2016-01-01
001 2016-01-01
001 2016-01-01
001 2015-01-01 JOHN C. BOWLES JOHN C. BOWLES 2018-07-12
001 2015-01-01
001 2015-01-01
001 2015-01-01
001 2015-01-01
001 2014-01-01 GREGORY TEBEAU
001 2014-01-01 GREGORY TEBEAU
001 2013-01-01 GREGORY TEBEAU 2014-10-14
001 2012-01-01 GREGORY TEBEAU 2013-10-14
001 2010-01-01 GREGORY TEBEAU 2011-10-14
001 2009-01-01 GREGORY TEBEAU GREGORY TEBEAU 2010-10-12

Plan Statistics for UNIVERSITY PHARMACEUTICALS OF M.D. 401(K) PLAN

401k plan membership statisitcs for UNIVERSITY PHARMACEUTICALS OF M.D. 401(K) PLAN

Measure Date Value
2022: UNIVERSITY PHARMACEUTICALS OF M.D. 401(K) PLAN 2022 401k membership
Total participants, beginning-of-year 2022-01-01 326
Total number of active participants reported on line 7a of the Form 5500 2022-01-01 266
Number of retired or separated participants receiving benefits 2022-01-01 0
Number of other retired or separated participants entitled to future benefits 2022-01-01 84
Total of all active and inactive participants 2022-01-01 350
Number of deceased participants whose beneficiaries are receiving or are entitled to receive benefits 2022-01-01 0
Total participants 2022-01-01 350
Number of participants with account balances 2022-01-01 233
Participants that terminated employment during the plan year with accrued benefits that were less than 100% vested 2022-01-01 17
2021: UNIVERSITY PHARMACEUTICALS OF M.D. 401(K) PLAN 2021 401k membership
Total participants, beginning-of-year 2021-01-01 316
Total number of active participants reported on line 7a of the Form 5500 2021-01-01 252
Number of retired or separated participants receiving benefits 2021-01-01 0
Number of other retired or separated participants entitled to future benefits 2021-01-01 73
Total of all active and inactive participants 2021-01-01 325
Number of deceased participants whose beneficiaries are receiving or are entitled to receive benefits 2021-01-01 0
Total participants 2021-01-01 325
Number of participants with account balances 2021-01-01 230
Participants that terminated employment during the plan year with accrued benefits that were less than 100% vested 2021-01-01 17
2020: UNIVERSITY PHARMACEUTICALS OF M.D. 401(K) PLAN 2020 401k membership
Total participants, beginning-of-year 2020-01-01 283
Total number of active participants reported on line 7a of the Form 5500 2020-01-01 250
Number of retired or separated participants receiving benefits 2020-01-01 0
Number of other retired or separated participants entitled to future benefits 2020-01-01 65
Total of all active and inactive participants 2020-01-01 315
Number of deceased participants whose beneficiaries are receiving or are entitled to receive benefits 2020-01-01 0
Total participants 2020-01-01 315
Number of participants with account balances 2020-01-01 222
Participants that terminated employment during the plan year with accrued benefits that were less than 100% vested 2020-01-01 10
2019: UNIVERSITY PHARMACEUTICALS OF M.D. 401(K) PLAN 2019 401k membership
Total participants, beginning-of-year 2019-01-01 311
Total number of active participants reported on line 7a of the Form 5500 2019-01-01 216
Number of retired or separated participants receiving benefits 2019-01-01 0
Number of other retired or separated participants entitled to future benefits 2019-01-01 67
Total of all active and inactive participants 2019-01-01 283
Number of deceased participants whose beneficiaries are receiving or are entitled to receive benefits 2019-01-01 0
Total participants 2019-01-01 283
Number of participants with account balances 2019-01-01 203
Participants that terminated employment during the plan year with accrued benefits that were less than 100% vested 2019-01-01 21
2018: UNIVERSITY PHARMACEUTICALS OF M.D. 401(K) PLAN 2018 401k membership
Total participants, beginning-of-year 2018-01-01 309
Total number of active participants reported on line 7a of the Form 5500 2018-01-01 251
Number of retired or separated participants receiving benefits 2018-01-01 0
Number of other retired or separated participants entitled to future benefits 2018-01-01 60
Total of all active and inactive participants 2018-01-01 311
Number of deceased participants whose beneficiaries are receiving or are entitled to receive benefits 2018-01-01 0
Total participants 2018-01-01 311
Number of participants with account balances 2018-01-01 213
Participants that terminated employment during the plan year with accrued benefits that were less than 100% vested 2018-01-01 22
2017: UNIVERSITY PHARMACEUTICALS OF M.D. 401(K) PLAN 2017 401k membership
Total participants, beginning-of-year 2017-01-01 273
Total number of active participants reported on line 7a of the Form 5500 2017-01-01 254
Number of retired or separated participants receiving benefits 2017-01-01 0
Number of other retired or separated participants entitled to future benefits 2017-01-01 55
Total of all active and inactive participants 2017-01-01 309
Number of deceased participants whose beneficiaries are receiving or are entitled to receive benefits 2017-01-01 0
Total participants 2017-01-01 309
Number of participants with account balances 2017-01-01 199
Participants that terminated employment during the plan year with accrued benefits that were less than 100% vested 2017-01-01 11
2016: UNIVERSITY PHARMACEUTICALS OF M.D. 401(K) PLAN 2016 401k membership
Total participants, beginning-of-year 2016-01-01 207
Total number of active participants reported on line 7a of the Form 5500 2016-01-01 225
Number of retired or separated participants receiving benefits 2016-01-01 0
Number of other retired or separated participants entitled to future benefits 2016-01-01 46
Total of all active and inactive participants 2016-01-01 271
Number of deceased participants whose beneficiaries are receiving or are entitled to receive benefits 2016-01-01 0
Total participants 2016-01-01 271
Number of participants with account balances 2016-01-01 174
Participants that terminated employment during the plan year with accrued benefits that were less than 100% vested 2016-01-01 18
2015: UNIVERSITY PHARMACEUTICALS OF M.D. 401(K) PLAN 2015 401k membership
Total participants, beginning-of-year 2015-01-01 172
Total number of active participants reported on line 7a of the Form 5500 2015-01-01 167
Number of retired or separated participants receiving benefits 2015-01-01 0
Number of other retired or separated participants entitled to future benefits 2015-01-01 35
Total of all active and inactive participants 2015-01-01 202
Number of deceased participants whose beneficiaries are receiving or are entitled to receive benefits 2015-01-01 0
Total participants 2015-01-01 202
Number of participants with account balances 2015-01-01 148
Participants that terminated employment during the plan year with accrued benefits that were less than 100% vested 2015-01-01 0
2014: UNIVERSITY PHARMACEUTICALS OF M.D. 401(K) PLAN 2014 401k membership
Total participants, beginning-of-year 2014-01-01 175
Total number of active participants reported on line 7a of the Form 5500 2014-01-01 143
Number of retired or separated participants receiving benefits 2014-01-01 0
Number of other retired or separated participants entitled to future benefits 2014-01-01 29
Total of all active and inactive participants 2014-01-01 172
Number of deceased participants whose beneficiaries are receiving or are entitled to receive benefits 2014-01-01 0
Total participants 2014-01-01 172
Number of participants with account balances 2014-01-01 130
Participants that terminated employment during the plan year with accrued benefits that were less than 100% vested 2014-01-01 2
2009: UNIVERSITY PHARMACEUTICALS OF M.D. 401(K) PLAN 2009 401k membership
Total participants, beginning-of-year 2009-01-01 79
Total number of active participants reported on line 7a of the Form 5500 2009-01-01 51
Number of retired or separated participants receiving benefits 2009-01-01 0
Number of other retired or separated participants entitled to future benefits 2009-01-01 16
Total of all active and inactive participants 2009-01-01 67
Number of deceased participants whose beneficiaries are receiving or are entitled to receive benefits 2009-01-01 0
Total participants 2009-01-01 67
Number of participants with account balances 2009-01-01 55
Participants that terminated employment during the plan year with accrued benefits that were less than 100% vested 2009-01-01 5

Measure	Date	Value
2022: UNIVERSITY PHARMACEUTICALS OF M.D. 401(K) PLAN 2022 401k membership
Total participants, beginning-of-year	2022-01-01	326
Total number of active participants reported on line 7a of the Form 5500	2022-01-01	266
Number of retired or separated participants receiving benefits	2022-01-01	0
Number of other retired or separated participants entitled to future benefits	2022-01-01	84
Total of all active and inactive participants	2022-01-01	350
Number of deceased participants whose beneficiaries are receiving or are entitled to receive benefits	2022-01-01	0
Total participants	2022-01-01	350
Number of participants with account balances	2022-01-01	233
Participants that terminated employment during the plan year with accrued benefits that were less than 100% vested	2022-01-01	17
2021: UNIVERSITY PHARMACEUTICALS OF M.D. 401(K) PLAN 2021 401k membership
Total participants, beginning-of-year	2021-01-01	316
Total number of active participants reported on line 7a of the Form 5500	2021-01-01	252
Number of retired or separated participants receiving benefits	2021-01-01	0
Number of other retired or separated participants entitled to future benefits	2021-01-01	73
Total of all active and inactive participants	2021-01-01	325
Number of deceased participants whose beneficiaries are receiving or are entitled to receive benefits	2021-01-01	0
Total participants	2021-01-01	325
Number of participants with account balances	2021-01-01	230
Participants that terminated employment during the plan year with accrued benefits that were less than 100% vested	2021-01-01	17
2020: UNIVERSITY PHARMACEUTICALS OF M.D. 401(K) PLAN 2020 401k membership
Total participants, beginning-of-year	2020-01-01	283
Total number of active participants reported on line 7a of the Form 5500	2020-01-01	250
Number of retired or separated participants receiving benefits	2020-01-01	0
Number of other retired or separated participants entitled to future benefits	2020-01-01	65
Total of all active and inactive participants	2020-01-01	315
Number of deceased participants whose beneficiaries are receiving or are entitled to receive benefits	2020-01-01	0
Total participants	2020-01-01	315
Number of participants with account balances	2020-01-01	222
Participants that terminated employment during the plan year with accrued benefits that were less than 100% vested	2020-01-01	10
2019: UNIVERSITY PHARMACEUTICALS OF M.D. 401(K) PLAN 2019 401k membership
Total participants, beginning-of-year	2019-01-01	311
Total number of active participants reported on line 7a of the Form 5500	2019-01-01	216
Number of retired or separated participants receiving benefits	2019-01-01	0
Number of other retired or separated participants entitled to future benefits	2019-01-01	67
Total of all active and inactive participants	2019-01-01	283
Number of deceased participants whose beneficiaries are receiving or are entitled to receive benefits	2019-01-01	0
Total participants	2019-01-01	283
Number of participants with account balances	2019-01-01	203
Participants that terminated employment during the plan year with accrued benefits that were less than 100% vested	2019-01-01	21
2018: UNIVERSITY PHARMACEUTICALS OF M.D. 401(K) PLAN 2018 401k membership
Total participants, beginning-of-year	2018-01-01	309
Total number of active participants reported on line 7a of the Form 5500	2018-01-01	251
Number of retired or separated participants receiving benefits	2018-01-01	0
Number of other retired or separated participants entitled to future benefits	2018-01-01	60
Total of all active and inactive participants	2018-01-01	311
Number of deceased participants whose beneficiaries are receiving or are entitled to receive benefits	2018-01-01	0
Total participants	2018-01-01	311
Number of participants with account balances	2018-01-01	213
Participants that terminated employment during the plan year with accrued benefits that were less than 100% vested	2018-01-01	22
2017: UNIVERSITY PHARMACEUTICALS OF M.D. 401(K) PLAN 2017 401k membership
Total participants, beginning-of-year	2017-01-01	273
Total number of active participants reported on line 7a of the Form 5500	2017-01-01	254
Number of retired or separated participants receiving benefits	2017-01-01	0
Number of other retired or separated participants entitled to future benefits	2017-01-01	55
Total of all active and inactive participants	2017-01-01	309
Number of deceased participants whose beneficiaries are receiving or are entitled to receive benefits	2017-01-01	0
Total participants	2017-01-01	309
Number of participants with account balances	2017-01-01	199
Participants that terminated employment during the plan year with accrued benefits that were less than 100% vested	2017-01-01	11
2016: UNIVERSITY PHARMACEUTICALS OF M.D. 401(K) PLAN 2016 401k membership
Total participants, beginning-of-year	2016-01-01	207
Total number of active participants reported on line 7a of the Form 5500	2016-01-01	225
Number of retired or separated participants receiving benefits	2016-01-01	0
Number of other retired or separated participants entitled to future benefits	2016-01-01	46
Total of all active and inactive participants	2016-01-01	271
Number of deceased participants whose beneficiaries are receiving or are entitled to receive benefits	2016-01-01	0
Total participants	2016-01-01	271
Number of participants with account balances	2016-01-01	174
Participants that terminated employment during the plan year with accrued benefits that were less than 100% vested	2016-01-01	18
2015: UNIVERSITY PHARMACEUTICALS OF M.D. 401(K) PLAN 2015 401k membership
Total participants, beginning-of-year	2015-01-01	172
Total number of active participants reported on line 7a of the Form 5500	2015-01-01	167
Number of retired or separated participants receiving benefits	2015-01-01	0
Number of other retired or separated participants entitled to future benefits	2015-01-01	35
Total of all active and inactive participants	2015-01-01	202
Number of deceased participants whose beneficiaries are receiving or are entitled to receive benefits	2015-01-01	0
Total participants	2015-01-01	202
Number of participants with account balances	2015-01-01	148
Participants that terminated employment during the plan year with accrued benefits that were less than 100% vested	2015-01-01	0
2014: UNIVERSITY PHARMACEUTICALS OF M.D. 401(K) PLAN 2014 401k membership
Total participants, beginning-of-year	2014-01-01	175
Total number of active participants reported on line 7a of the Form 5500	2014-01-01	143
Number of retired or separated participants receiving benefits	2014-01-01	0
Number of other retired or separated participants entitled to future benefits	2014-01-01	29
Total of all active and inactive participants	2014-01-01	172
Number of deceased participants whose beneficiaries are receiving or are entitled to receive benefits	2014-01-01	0
Total participants	2014-01-01	172
Number of participants with account balances	2014-01-01	130
Participants that terminated employment during the plan year with accrued benefits that were less than 100% vested	2014-01-01	2
2009: UNIVERSITY PHARMACEUTICALS OF M.D. 401(K) PLAN 2009 401k membership
Total participants, beginning-of-year	2009-01-01	79
Total number of active participants reported on line 7a of the Form 5500	2009-01-01	51
Number of retired or separated participants receiving benefits	2009-01-01	0
Number of other retired or separated participants entitled to future benefits	2009-01-01	16
Total of all active and inactive participants	2009-01-01	67
Number of deceased participants whose beneficiaries are receiving or are entitled to receive benefits	2009-01-01	0
Total participants	2009-01-01	67
Number of participants with account balances	2009-01-01	55
Participants that terminated employment during the plan year with accrued benefits that were less than 100% vested	2009-01-01	5

Financial Data on UNIVERSITY PHARMACEUTICALS OF M.D. 401(K) PLAN

Measure	Date	Value
2022 : UNIVERSITY PHARMACEUTICALS OF M.D. 401(K) PLAN 2022 401k financial data
Total unrealized appreciation/depreciation of assets	2022-12-31	$0
Total liabilities at end of year (benefit claims payable, operating payabales, acquisition indebtedness and other liabilities)	2022-12-31	$0
Total liabilities at beginning of year (benefit claims payable, operating payabales, acquisition indebtedness and other liabilities)	2022-12-31	$0
Total income from all sources (including contributions)	2022-12-31	$-816,924
Total loss/gain on sale of assets	2022-12-31	$0
Total of all expenses incurred	2022-12-31	$908,534
Benefit payments and payments to participlants,beneficiaries,insurance carriers and others	2022-12-31	$816,929
Total contributions o plan (from employers,participants, others, non cash contrinutions)	2022-12-31	$1,400,836
Value of total assets at end of year	2022-12-31	$10,319,130
Value of total assets at beginning of year	2022-12-31	$12,044,588
Total of administrative expenses incurred including professional, contract, advisory and management fees	2022-12-31	$91,605
Total interest from all sources	2022-12-31	$2,528
Total dividends received (eg from common stock, registered investment company shares)	2022-12-31	$149,066
Has a resolution to terminate the plan been adopted during the plan year or any prior plan year	2022-12-31	No
Total dividends received from registered investment company shares (eg mutual funds)	2022-12-31	$149,066
Administrative expenses professional fees incurred	2022-12-31	$16,143
Was this plan covered by a fidelity bond	2022-12-31	Yes
Value of fidelity bond cover	2022-12-31	$500,000
If this is an individual account plan, was there a blackout period	2022-12-31	No
Were there any nonexempt tranactions with any party-in-interest	2022-12-31	No
Contributions received from participants	2022-12-31	$920,343
Participant contributions at end of year	2022-12-31	$40,800
Participant contributions at beginning of year	2022-12-31	$63,293
Income. Received or receivable in cash from other sources (including rollovers)	2022-12-31	$12,446
Did the receive any noncash contributions whose value was neither redily determinable on an established market nor set by an independent third party appraiser	2022-12-31	No
Value of net income/loss	2022-12-31	$-1,725,458
Value of net assets at end of year (total assets less liabilities)	2022-12-31	$10,319,130
Value of net assets at beginning of year (total assets less liabilities)	2022-12-31	$12,044,588
Did the plan have a loss casued by fraud or dishonesty (regardless whether reimbursed by fidelity bond)	2022-12-31	No
Were any loans by the plan or fixed income obligations due to the plan in default	2022-12-31	No
Were any leases to which the plan was party in default or uncollectible	2022-12-31	No
Investment advisory and management fees	2022-12-31	$53,625
Value of interest in registered invesment companies (eg mutual funds) at end of year	2022-12-31	$10,278,330
Value of interest in registered invesment companies (eg mutual funds) at beginning of year	2022-12-31	$11,981,295
Interest on participant loans	2022-12-31	$2,528
Income. Interest from loans (other than to participants)	2022-12-31	$0
Net investment gain/loss from registered investment companies (e.g. mutual funds)	2022-12-31	$-2,369,354
Were any plan transactions or series of transactions in excess of 5% of the current value of the plan assets	2022-12-31	No
Was there a failure to transmit to the plan any participant contributions	2022-12-31	No
Has the plan failed to provide any benefit when due under the plan	2022-12-31	No
Contributions received in cash from employer	2022-12-31	$468,047
Benefit payments and payments to provide benefits directly to participlants or beneficiaries including direct rollovers	2022-12-31	$816,929
Contract administrator fees	2022-12-31	$21,837
Did the plan have assets held for investment	2022-12-31	Yes
Did the plan hold any assets whose current value was neither redily determinable on an established market nor set by an independent third party appraiser	2022-12-31	No
Were all the plan assets eitehr distributed to particpants/beneficiaries, transferred to another plan or brought under the control of the PBGC	2022-12-31	No
Opinion of an independent qualified public accountant for this plan	2022-12-31	Unqualified
Accountancy firm name	2022-12-31	BROWN,EDWARDS & COMPANY, LLP
Accountancy firm EIN	2022-12-31	540504608
2021 : UNIVERSITY PHARMACEUTICALS OF M.D. 401(K) PLAN 2021 401k financial data
Total unrealized appreciation/depreciation of assets	2021-12-31	$0
Total liabilities at end of year (benefit claims payable, operating payabales, acquisition indebtedness and other liabilities)	2021-12-31	$0
Total liabilities at beginning of year (benefit claims payable, operating payabales, acquisition indebtedness and other liabilities)	2021-12-31	$0
Total income from all sources (including contributions)	2021-12-31	$2,942,004
Total loss/gain on sale of assets	2021-12-31	$0
Total of all expenses incurred	2021-12-31	$1,751,634
Benefit payments and payments to participlants,beneficiaries,insurance carriers and others	2021-12-31	$1,654,595
Total contributions o plan (from employers,participants, others, non cash contrinutions)	2021-12-31	$1,356,314
Value of total assets at end of year	2021-12-31	$12,044,588
Value of total assets at beginning of year	2021-12-31	$10,854,218
Total of administrative expenses incurred including professional, contract, advisory and management fees	2021-12-31	$97,039
Total interest from all sources	2021-12-31	$3,004
Total dividends received (eg from common stock, registered investment company shares)	2021-12-31	$110,578
Has a resolution to terminate the plan been adopted during the plan year or any prior plan year	2021-12-31	No
Total dividends received from registered investment company shares (eg mutual funds)	2021-12-31	$110,578
Was this plan covered by a fidelity bond	2021-12-31	Yes
Value of fidelity bond cover	2021-12-31	$500,000
If this is an individual account plan, was there a blackout period	2021-12-31	No
Were there any nonexempt tranactions with any party-in-interest	2021-12-31	No
Contributions received from participants	2021-12-31	$904,596
Participant contributions at end of year	2021-12-31	$63,293
Participant contributions at beginning of year	2021-12-31	$21,888
Administrative expenses (other) incurred	2021-12-31	$15,369
Did the receive any noncash contributions whose value was neither redily determinable on an established market nor set by an independent third party appraiser	2021-12-31	No
Value of net income/loss	2021-12-31	$1,190,370
Value of net assets at end of year (total assets less liabilities)	2021-12-31	$12,044,588
Value of net assets at beginning of year (total assets less liabilities)	2021-12-31	$10,854,218
Did the plan have a loss casued by fraud or dishonesty (regardless whether reimbursed by fidelity bond)	2021-12-31	No
Were any loans by the plan or fixed income obligations due to the plan in default	2021-12-31	No
Were any leases to which the plan was party in default or uncollectible	2021-12-31	No
Investment advisory and management fees	2021-12-31	$57,557
Value of interest in registered invesment companies (eg mutual funds) at end of year	2021-12-31	$11,981,295
Value of interest in registered invesment companies (eg mutual funds) at beginning of year	2021-12-31	$10,832,330
Interest on participant loans	2021-12-31	$3,004
Net investment gain/loss from registered investment companies (e.g. mutual funds)	2021-12-31	$1,472,108
Were any plan transactions or series of transactions in excess of 5% of the current value of the plan assets	2021-12-31	No
Was there a failure to transmit to the plan any participant contributions	2021-12-31	No
Has the plan failed to provide any benefit when due under the plan	2021-12-31	No
Contributions received in cash from employer	2021-12-31	$451,718
Benefit payments and payments to provide benefits directly to participlants or beneficiaries including direct rollovers	2021-12-31	$1,654,595
Contract administrator fees	2021-12-31	$24,113
Did the plan have assets held for investment	2021-12-31	Yes
Did the plan hold any assets whose current value was neither redily determinable on an established market nor set by an independent third party appraiser	2021-12-31	No
Were all the plan assets eitehr distributed to particpants/beneficiaries, transferred to another plan or brought under the control of the PBGC	2021-12-31	No
Opinion of an independent qualified public accountant for this plan	2021-12-31	Unqualified
Accountancy firm name	2021-12-31	BROWN,EDWARDS & COMPANY, LLP
Accountancy firm EIN	2021-12-31	540504608
2020 : UNIVERSITY PHARMACEUTICALS OF M.D. 401(K) PLAN 2020 401k financial data
Total unrealized appreciation/depreciation of assets	2020-12-31	$0
Total liabilities at end of year (benefit claims payable, operating payabales, acquisition indebtedness and other liabilities)	2020-12-31	$0
Total liabilities at beginning of year (benefit claims payable, operating payabales, acquisition indebtedness and other liabilities)	2020-12-31	$0
Total income from all sources (including contributions)	2020-12-31	$3,103,863
Total loss/gain on sale of assets	2020-12-31	$0
Total of all expenses incurred	2020-12-31	$1,245,688
Benefit payments and payments to participlants,beneficiaries,insurance carriers and others	2020-12-31	$1,166,441
Total contributions o plan (from employers,participants, others, non cash contrinutions)	2020-12-31	$1,311,576
Value of total assets at end of year	2020-12-31	$10,854,218
Value of total assets at beginning of year	2020-12-31	$8,996,043
Total of administrative expenses incurred including professional, contract, advisory and management fees	2020-12-31	$79,247
Total interest from all sources	2020-12-31	$2,027
Total dividends received (eg from common stock, registered investment company shares)	2020-12-31	$112,835
Has a resolution to terminate the plan been adopted during the plan year or any prior plan year	2020-12-31	No
Total dividends received from registered investment company shares (eg mutual funds)	2020-12-31	$112,835
Administrative expenses professional fees incurred	2020-12-31	$14,919
Was this plan covered by a fidelity bond	2020-12-31	Yes
Value of fidelity bond cover	2020-12-31	$500,000
If this is an individual account plan, was there a blackout period	2020-12-31	No
Total value of distributions paid in property other than in cash, annuity contracts, or publicly traded employer securities	2020-12-31	$0
Were there any nonexempt tranactions with any party-in-interest	2020-12-31	No
Contributions received from participants	2020-12-31	$890,761
Participant contributions at end of year	2020-12-31	$21,888
Participant contributions at beginning of year	2020-12-31	$29,135
Income. Received or receivable in cash from other sources (including rollovers)	2020-12-31	$1,804
Did the receive any noncash contributions whose value was neither redily determinable on an established market nor set by an independent third party appraiser	2020-12-31	No
Value of net income/loss	2020-12-31	$1,858,175
Value of net assets at end of year (total assets less liabilities)	2020-12-31	$10,854,218
Value of net assets at beginning of year (total assets less liabilities)	2020-12-31	$8,996,043
Did the plan have a loss casued by fraud or dishonesty (regardless whether reimbursed by fidelity bond)	2020-12-31	No
Were any loans by the plan or fixed income obligations due to the plan in default	2020-12-31	No
Were any leases to which the plan was party in default or uncollectible	2020-12-31	No
Investment advisory and management fees	2020-12-31	$43,559
Value of interest in registered invesment companies (eg mutual funds) at end of year	2020-12-31	$10,832,330
Value of interest in registered invesment companies (eg mutual funds) at beginning of year	2020-12-31	$8,966,908
Interest on participant loans	2020-12-31	$2,027
Income. Interest from loans (other than to participants)	2020-12-31	$0
Net investment gain/loss from registered investment companies (e.g. mutual funds)	2020-12-31	$1,677,425
Were any plan transactions or series of transactions in excess of 5% of the current value of the plan assets	2020-12-31	No
Was there a failure to transmit to the plan any participant contributions	2020-12-31	No
Has the plan failed to provide any benefit when due under the plan	2020-12-31	Yes
Contributions received in cash from employer	2020-12-31	$419,011
Benefit payments and payments to provide benefits directly to participlants or beneficiaries including direct rollovers	2020-12-31	$1,166,441
Contract administrator fees	2020-12-31	$20,769
Did the plan have assets held for investment	2020-12-31	Yes
Did the plan hold any assets whose current value was neither redily determinable on an established market nor set by an independent third party appraiser	2020-12-31	No
Were all the plan assets eitehr distributed to particpants/beneficiaries, transferred to another plan or brought under the control of the PBGC	2020-12-31	No
Opinion of an independent qualified public accountant for this plan	2020-12-31	Disclaimer
Accountancy firm name	2020-12-31	BROWN,EDWARDS & COMPANY, LLP
Accountancy firm EIN	2020-12-31	540504608
2019 : UNIVERSITY PHARMACEUTICALS OF M.D. 401(K) PLAN 2019 401k financial data
Total unrealized appreciation/depreciation of assets	2019-12-31	$0
Total liabilities at end of year (benefit claims payable, operating payabales, acquisition indebtedness and other liabilities)	2019-12-31	$0
Total liabilities at beginning of year (benefit claims payable, operating payabales, acquisition indebtedness and other liabilities)	2019-12-31	$0
Total income from all sources (including contributions)	2019-12-31	$3,095,189
Total loss/gain on sale of assets	2019-12-31	$0
Total of all expenses incurred	2019-12-31	$1,507,515
Benefit payments and payments to participlants,beneficiaries,insurance carriers and others	2019-12-31	$1,436,157
Total contributions o plan (from employers,participants, others, non cash contrinutions)	2019-12-31	$1,239,741
Value of total assets at end of year	2019-12-31	$8,996,043
Value of total assets at beginning of year	2019-12-31	$7,408,369
Total of administrative expenses incurred including professional, contract, advisory and management fees	2019-12-31	$71,358
Total interest from all sources	2019-12-31	$1,998
Total dividends received (eg from common stock, registered investment company shares)	2019-12-31	$121,129
Has a resolution to terminate the plan been adopted during the plan year or any prior plan year	2019-12-31	No
Total dividends received from registered investment company shares (eg mutual funds)	2019-12-31	$121,129
Administrative expenses professional fees incurred	2019-12-31	$4,008
Was this plan covered by a fidelity bond	2019-12-31	Yes
Value of fidelity bond cover	2019-12-31	$500,000
If this is an individual account plan, was there a blackout period	2019-12-31	No
Total value of distributions paid in property other than in cash, annuity contracts, or publicly traded employer securities	2019-12-31	$0
Were there any nonexempt tranactions with any party-in-interest	2019-12-31	No
Contributions received from participants	2019-12-31	$827,996
Participant contributions at end of year	2019-12-31	$29,135
Participant contributions at beginning of year	2019-12-31	$13,366
Participant contributions at end of year	2019-12-31	$0
Participant contributions at beginning of year	2019-12-31	$24,993
Income. Received or receivable in cash from other sources (including rollovers)	2019-12-31	$9,789
Did the receive any noncash contributions whose value was neither redily determinable on an established market nor set by an independent third party appraiser	2019-12-31	No
Value of net income/loss	2019-12-31	$1,587,674
Value of net assets at end of year (total assets less liabilities)	2019-12-31	$8,996,043
Value of net assets at beginning of year (total assets less liabilities)	2019-12-31	$7,408,369
Did the plan have a loss casued by fraud or dishonesty (regardless whether reimbursed by fidelity bond)	2019-12-31	No
Were any loans by the plan or fixed income obligations due to the plan in default	2019-12-31	No
Were any leases to which the plan was party in default or uncollectible	2019-12-31	No
Investment advisory and management fees	2019-12-31	$47,118
Value of interest in registered invesment companies (eg mutual funds) at end of year	2019-12-31	$8,966,908
Value of interest in registered invesment companies (eg mutual funds) at beginning of year	2019-12-31	$7,355,064
Interest on participant loans	2019-12-31	$1,998
Income. Interest from loans (other than to participants)	2019-12-31	$0
Net investment gain/loss from registered investment companies (e.g. mutual funds)	2019-12-31	$1,732,321
Were any plan transactions or series of transactions in excess of 5% of the current value of the plan assets	2019-12-31	No
Was there a failure to transmit to the plan any participant contributions	2019-12-31	No
Has the plan failed to provide any benefit when due under the plan	2019-12-31	No
Contributions received in cash from employer	2019-12-31	$401,956
Employer contributions (assets) at end of year	2019-12-31	$0
Employer contributions (assets) at beginning of year	2019-12-31	$14,946
Benefit payments and payments to provide benefits directly to participlants or beneficiaries including direct rollovers	2019-12-31	$1,436,157
Contract administrator fees	2019-12-31	$20,232
Did the plan have assets held for investment	2019-12-31	Yes
Did the plan hold any assets whose current value was neither redily determinable on an established market nor set by an independent third party appraiser	2019-12-31	No
Were all the plan assets eitehr distributed to particpants/beneficiaries, transferred to another plan or brought under the control of the PBGC	2019-12-31	No
Accountant perfomed limited scope audit pursuant to 29 CFR 2520.103-8 and/or 103-12(d)	2019-12-31	Yes
Opinion of an independent qualified public accountant for this plan	2019-12-31	Disclaimer
Accountancy firm name	2019-12-31	BROWN,EDWARDS & COMPANY, LLP
Accountancy firm EIN	2019-12-31	540504608
2018 : UNIVERSITY PHARMACEUTICALS OF M.D. 401(K) PLAN 2018 401k financial data
Total unrealized appreciation/depreciation of assets	2018-12-31	$0
Total liabilities at end of year (benefit claims payable, operating payabales, acquisition indebtedness and other liabilities)	2018-12-31	$0
Total liabilities at beginning of year (benefit claims payable, operating payabales, acquisition indebtedness and other liabilities)	2018-12-31	$0
Total income from all sources (including contributions)	2018-12-31	$1,263,381
Total loss/gain on sale of assets	2018-12-31	$0
Total of all expenses incurred	2018-12-31	$1,219,190
Benefit payments and payments to participlants,beneficiaries,insurance carriers and others	2018-12-31	$1,142,490
Value of total corrective distributions	2018-12-31	$7,047
Total contributions o plan (from employers,participants, others, non cash contrinutions)	2018-12-31	$1,684,941
Value of total assets at end of year	2018-12-31	$7,408,369
Value of total assets at beginning of year	2018-12-31	$7,364,178
Total of administrative expenses incurred including professional, contract, advisory and management fees	2018-12-31	$69,653
Total interest from all sources	2018-12-31	$709
Total dividends received (eg from common stock, registered investment company shares)	2018-12-31	$102,639
Has a resolution to terminate the plan been adopted during the plan year or any prior plan year	2018-12-31	No
Total dividends received from registered investment company shares (eg mutual funds)	2018-12-31	$102,639
Administrative expenses professional fees incurred	2018-12-31	$12,684
Was this plan covered by a fidelity bond	2018-12-31	Yes
Value of fidelity bond cover	2018-12-31	$500,000
If this is an individual account plan, was there a blackout period	2018-12-31	No
Total value of distributions paid in property other than in cash, annuity contracts, or publicly traded employer securities	2018-12-31	$0
Were there any nonexempt tranactions with any party-in-interest	2018-12-31	No
Contributions received from participants	2018-12-31	$979,248
Participant contributions at end of year	2018-12-31	$13,366
Participant contributions at beginning of year	2018-12-31	$15,432
Participant contributions at end of year	2018-12-31	$24,993
Participant contributions at beginning of year	2018-12-31	$993
Income. Received or receivable in cash from other sources (including rollovers)	2018-12-31	$292,909
Did the receive any noncash contributions whose value was neither redily determinable on an established market nor set by an independent third party appraiser	2018-12-31	No
Value of net income/loss	2018-12-31	$44,191
Value of net assets at end of year (total assets less liabilities)	2018-12-31	$7,408,369
Value of net assets at beginning of year (total assets less liabilities)	2018-12-31	$7,364,178
Did the plan have a loss casued by fraud or dishonesty (regardless whether reimbursed by fidelity bond)	2018-12-31	No
Were any loans by the plan or fixed income obligations due to the plan in default	2018-12-31	No
Were any leases to which the plan was party in default or uncollectible	2018-12-31	No
Investment advisory and management fees	2018-12-31	$38,015
Value of interest in registered invesment companies (eg mutual funds) at end of year	2018-12-31	$7,355,064
Value of interest in registered invesment companies (eg mutual funds) at beginning of year	2018-12-31	$7,347,753
Interest on participant loans	2018-12-31	$709
Income. Interest from loans (other than to participants)	2018-12-31	$0
Net investment gain/loss from registered investment companies (e.g. mutual funds)	2018-12-31	$-524,908
Were any plan transactions or series of transactions in excess of 5% of the current value of the plan assets	2018-12-31	No
Was there a failure to transmit to the plan any participant contributions	2018-12-31	No
Has the plan failed to provide any benefit when due under the plan	2018-12-31	No
Contributions received in cash from employer	2018-12-31	$412,784
Employer contributions (assets) at end of year	2018-12-31	$14,946
Benefit payments and payments to provide benefits directly to participlants or beneficiaries including direct rollovers	2018-12-31	$1,142,490
Contract administrator fees	2018-12-31	$18,954
Did the plan have assets held for investment	2018-12-31	Yes
Did the plan hold any assets whose current value was neither redily determinable on an established market nor set by an independent third party appraiser	2018-12-31	No
Were all the plan assets eitehr distributed to particpants/beneficiaries, transferred to another plan or brought under the control of the PBGC	2018-12-31	No
Accountant perfomed limited scope audit pursuant to 29 CFR 2520.103-8 and/or 103-12(d)	2018-12-31	Yes
Opinion of an independent qualified public accountant for this plan	2018-12-31	Disclaimer
Accountancy firm name	2018-12-31	BROWN,EDWARDS & COMPANY, LLP
Accountancy firm EIN	2018-12-31	540504608
2017 : UNIVERSITY PHARMACEUTICALS OF M.D. 401(K) PLAN 2017 401k financial data
Total unrealized appreciation/depreciation of assets	2017-12-31	$0
Total liabilities at end of year (benefit claims payable, operating payabales, acquisition indebtedness and other liabilities)	2017-12-31	$0
Total liabilities at beginning of year (benefit claims payable, operating payabales, acquisition indebtedness and other liabilities)	2017-12-31	$0
Total income from all sources (including contributions)	2017-12-31	$2,326,366
Total loss/gain on sale of assets	2017-12-31	$0
Total of all expenses incurred	2017-12-31	$157,949
Benefit payments and payments to participlants,beneficiaries,insurance carriers and others	2017-12-31	$111,213
Total contributions o plan (from employers,participants, others, non cash contrinutions)	2017-12-31	$1,280,677
Value of total assets at end of year	2017-12-31	$7,364,178
Value of total assets at beginning of year	2017-12-31	$5,195,761
Total of administrative expenses incurred including professional, contract, advisory and management fees	2017-12-31	$46,736
Total interest from all sources	2017-12-31	$664
Total dividends received (eg from common stock, registered investment company shares)	2017-12-31	$87,366
Has a resolution to terminate the plan been adopted during the plan year or any prior plan year	2017-12-31	No
Total dividends received from registered investment company shares (eg mutual funds)	2017-12-31	$87,366
Was this plan covered by a fidelity bond	2017-12-31	Yes
Value of fidelity bond cover	2017-12-31	$500,000
If this is an individual account plan, was there a blackout period	2017-12-31	No
Total value of distributions paid in property other than in cash, annuity contracts, or publicly traded employer securities	2017-12-31	$0
Were there any nonexempt tranactions with any party-in-interest	2017-12-31	No
Contributions received from participants	2017-12-31	$870,243
Participant contributions at end of year	2017-12-31	$15,432
Participant contributions at beginning of year	2017-12-31	$3,552
Participant contributions at end of year	2017-12-31	$993
Income. Received or receivable in cash from other sources (including rollovers)	2017-12-31	$604
Did the receive any noncash contributions whose value was neither redily determinable on an established market nor set by an independent third party appraiser	2017-12-31	No
Value of net income/loss	2017-12-31	$2,168,417
Value of net assets at end of year (total assets less liabilities)	2017-12-31	$7,364,178
Value of net assets at beginning of year (total assets less liabilities)	2017-12-31	$5,195,761
Did the plan have a loss casued by fraud or dishonesty (regardless whether reimbursed by fidelity bond)	2017-12-31	No
Were any loans by the plan or fixed income obligations due to the plan in default	2017-12-31	No
Were any leases to which the plan was party in default or uncollectible	2017-12-31	No
Investment advisory and management fees	2017-12-31	$29,836
Value of interest in registered invesment companies (eg mutual funds) at end of year	2017-12-31	$7,347,753
Value of interest in registered invesment companies (eg mutual funds) at beginning of year	2017-12-31	$5,192,209
Interest on participant loans	2017-12-31	$664
Net investment gain/loss from registered investment companies (e.g. mutual funds)	2017-12-31	$957,659
Were any plan transactions or series of transactions in excess of 5% of the current value of the plan assets	2017-12-31	No
Was there a failure to transmit to the plan any participant contributions	2017-12-31	No
Has the plan failed to provide any benefit when due under the plan	2017-12-31	No
Contributions received in cash from employer	2017-12-31	$409,830
Benefit payments and payments to provide benefits directly to participlants or beneficiaries including direct rollovers	2017-12-31	$111,213
Contract administrator fees	2017-12-31	$16,900
Did the plan have assets held for investment	2017-12-31	Yes
Did the plan hold any assets whose current value was neither redily determinable on an established market nor set by an independent third party appraiser	2017-12-31	No
Were all the plan assets eitehr distributed to particpants/beneficiaries, transferred to another plan or brought under the control of the PBGC	2017-12-31	No
Accountant perfomed limited scope audit pursuant to 29 CFR 2520.103-8 and/or 103-12(d)	2017-12-31	No
Opinion of an independent qualified public accountant for this plan	2017-12-31	Unqualified
Accountancy firm name	2017-12-31	BROWN,EDWARDS & COMPANY, LLP
Accountancy firm EIN	2017-12-31	540504608
2016 : UNIVERSITY PHARMACEUTICALS OF M.D. 401(K) PLAN 2016 401k financial data
Total unrealized appreciation/depreciation of assets	2016-12-31	$0
Total liabilities at end of year (benefit claims payable, operating payabales, acquisition indebtedness and other liabilities)	2016-12-31	$0
Total liabilities at beginning of year (benefit claims payable, operating payabales, acquisition indebtedness and other liabilities)	2016-12-31	$0
Total income from all sources (including contributions)	2016-12-31	$1,652,322
Total loss/gain on sale of assets	2016-12-31	$0
Total of all expenses incurred	2016-12-31	$1,371,429
Benefit payments and payments to participlants,beneficiaries,insurance carriers and others	2016-12-31	$1,330,323
Total contributions o plan (from employers,participants, others, non cash contrinutions)	2016-12-31	$1,316,704
Value of total assets at end of year	2016-12-31	$5,195,761
Value of total assets at beginning of year	2016-12-31	$4,914,868
Total of administrative expenses incurred including professional, contract, advisory and management fees	2016-12-31	$41,106
Total interest from all sources	2016-12-31	$204
Total dividends received (eg from common stock, registered investment company shares)	2016-12-31	$68,143
Has a resolution to terminate the plan been adopted during the plan year or any prior plan year	2016-12-31	No
Total dividends received from registered investment company shares (eg mutual funds)	2016-12-31	$68,143
Was this plan covered by a fidelity bond	2016-12-31	Yes
Value of fidelity bond cover	2016-12-31	$500,000
If this is an individual account plan, was there a blackout period	2016-12-31	No
Total value of distributions paid in property other than in cash, annuity contracts, or publicly traded employer securities	2016-12-31	$0
Were there any nonexempt tranactions with any party-in-interest	2016-12-31	No
Contributions received from participants	2016-12-31	$886,353
Participant contributions at end of year	2016-12-31	$3,552
Participant contributions at beginning of year	2016-12-31	$14,114
Participant contributions at end of year	2016-12-31	$0
Participant contributions at beginning of year	2016-12-31	$8,642
Income. Received or receivable in cash from other sources (including rollovers)	2016-12-31	$39,735
Did the receive any noncash contributions whose value was neither redily determinable on an established market nor set by an independent third party appraiser	2016-12-31	No
Value of net income/loss	2016-12-31	$280,893
Value of net assets at end of year (total assets less liabilities)	2016-12-31	$5,195,761
Value of net assets at beginning of year (total assets less liabilities)	2016-12-31	$4,914,868
Did the plan have a loss casued by fraud or dishonesty (regardless whether reimbursed by fidelity bond)	2016-12-31	No
Were any loans by the plan or fixed income obligations due to the plan in default	2016-12-31	No
Were any leases to which the plan was party in default or uncollectible	2016-12-31	No
Investment advisory and management fees	2016-12-31	$25,844
Value of interest in registered invesment companies (eg mutual funds) at end of year	2016-12-31	$5,192,209
Value of interest in registered invesment companies (eg mutual funds) at beginning of year	2016-12-31	$4,887,445
Interest on participant loans	2016-12-31	$0
Income. Interest from loans (other than to participants)	2016-12-31	$204
Net investment gain/loss from registered investment companies (e.g. mutual funds)	2016-12-31	$267,271
Were any plan transactions or series of transactions in excess of 5% of the current value of the plan assets	2016-12-31	No
Was there a failure to transmit to the plan any participant contributions	2016-12-31	No
Has the plan failed to provide any benefit when due under the plan	2016-12-31	No
Contributions received in cash from employer	2016-12-31	$390,616
Employer contributions (assets) at end of year	2016-12-31	$0
Employer contributions (assets) at beginning of year	2016-12-31	$4,667
Benefit payments and payments to provide benefits directly to participlants or beneficiaries including direct rollovers	2016-12-31	$1,330,323
Contract administrator fees	2016-12-31	$15,262
Did the plan have assets held for investment	2016-12-31	Yes
Did the plan hold any assets whose current value was neither redily determinable on an established market nor set by an independent third party appraiser	2016-12-31	No
Were all the plan assets eitehr distributed to particpants/beneficiaries, transferred to another plan or brought under the control of the PBGC	2016-12-31	No
Accountant perfomed limited scope audit pursuant to 29 CFR 2520.103-8 and/or 103-12(d)	2016-12-31	No
Opinion of an independent qualified public accountant for this plan	2016-12-31	Unqualified
Accountancy firm name	2016-12-31	BROWN,EDWARDS & COMPANY, LLP
Accountancy firm EIN	2016-12-31	540504608
2015 : UNIVERSITY PHARMACEUTICALS OF M.D. 401(K) PLAN 2015 401k financial data
Total unrealized appreciation/depreciation of assets	2015-12-31	$0
Total liabilities at end of year (benefit claims payable, operating payabales, acquisition indebtedness and other liabilities)	2015-12-31	$0
Total liabilities at beginning of year (benefit claims payable, operating payabales, acquisition indebtedness and other liabilities)	2015-12-31	$0
Total income from all sources (including contributions)	2015-12-31	$1,269,017
Total loss/gain on sale of assets	2015-12-31	$0
Total of all expenses incurred	2015-12-31	$1,317,324
Benefit payments and payments to participlants,beneficiaries,insurance carriers and others	2015-12-31	$1,276,126
Value of total corrective distributions	2015-12-31	$3,435
Total contributions o plan (from employers,participants, others, non cash contrinutions)	2015-12-31	$1,206,621
Value of total assets at end of year	2015-12-31	$4,914,868
Value of total assets at beginning of year	2015-12-31	$4,963,175
Total of administrative expenses incurred including professional, contract, advisory and management fees	2015-12-31	$37,763
Total interest from all sources	2015-12-31	$725
Total dividends received (eg from common stock, registered investment company shares)	2015-12-31	$51,390
Has a resolution to terminate the plan been adopted during the plan year or any prior plan year	2015-12-31	No
Total dividends received from registered investment company shares (eg mutual funds)	2015-12-31	$51,390
Was this plan covered by a fidelity bond	2015-12-31	Yes
Value of fidelity bond cover	2015-12-31	$500,000
If this is an individual account plan, was there a blackout period	2015-12-31	No
Total value of distributions paid in property other than in cash, annuity contracts, or publicly traded employer securities	2015-12-31	$0
Were there any nonexempt tranactions with any party-in-interest	2015-12-31	No
Contributions received from participants	2015-12-31	$798,372
Participant contributions at end of year	2015-12-31	$14,114
Participant contributions at beginning of year	2015-12-31	$14,738
Participant contributions at end of year	2015-12-31	$8,642
Income. Received or receivable in cash from other sources (including rollovers)	2015-12-31	$62,646
Did the receive any noncash contributions whose value was neither redily determinable on an established market nor set by an independent third party appraiser	2015-12-31	No
Value of net income/loss	2015-12-31	$-48,307
Value of net assets at end of year (total assets less liabilities)	2015-12-31	$4,914,868
Value of net assets at beginning of year (total assets less liabilities)	2015-12-31	$4,963,175
Did the plan have a loss casued by fraud or dishonesty (regardless whether reimbursed by fidelity bond)	2015-12-31	No
Were any loans by the plan or fixed income obligations due to the plan in default	2015-12-31	No
Were any leases to which the plan was party in default or uncollectible	2015-12-31	No
Investment advisory and management fees	2015-12-31	$25,033
Value of interest in registered invesment companies (eg mutual funds) at end of year	2015-12-31	$4,887,445
Value of interest in registered invesment companies (eg mutual funds) at beginning of year	2015-12-31	$4,945,062
Interest on participant loans	2015-12-31	$725
Interest-bearing cash (include money market accounts & certificates of deposit) at beginning of the Year	2015-12-31	$3,375
Value of interest bearing cash (including money market accounts and certificates of deposits) at beginning of year	2015-12-31	$3,375
Net investment gain/loss from registered investment companies (e.g. mutual funds)	2015-12-31	$10,281
Were any plan transactions or series of transactions in excess of 5% of the current value of the plan assets	2015-12-31	No
Was there a failure to transmit to the plan any participant contributions	2015-12-31	No
Has the plan failed to provide any benefit when due under the plan	2015-12-31	No
Contributions received in cash from employer	2015-12-31	$345,603
Employer contributions (assets) at end of year	2015-12-31	$4,667
Benefit payments and payments to provide benefits directly to participlants or beneficiaries including direct rollovers	2015-12-31	$1,276,126
Contract administrator fees	2015-12-31	$12,730
Did the plan have assets held for investment	2015-12-31	Yes
Did the plan hold any assets whose current value was neither redily determinable on an established market nor set by an independent third party appraiser	2015-12-31	No
Were all the plan assets eitehr distributed to particpants/beneficiaries, transferred to another plan or brought under the control of the PBGC	2015-12-31	No
Accountant perfomed limited scope audit pursuant to 29 CFR 2520.103-8 and/or 103-12(d)	2015-12-31	No
Opinion of an independent qualified public accountant for this plan	2015-12-31	Unqualified
Accountancy firm name	2015-12-31	BROWN,EDWARDS & COMPANY, LLP
Accountancy firm EIN	2015-12-31	540504608
2014 : UNIVERSITY PHARMACEUTICALS OF M.D. 401(K) PLAN 2014 401k financial data
Total unrealized appreciation/depreciation of assets	2014-12-31	$0
Total liabilities at end of year (benefit claims payable, operating payabales, acquisition indebtedness and other liabilities)	2014-12-31	$0
Total liabilities at beginning of year (benefit claims payable, operating payabales, acquisition indebtedness and other liabilities)	2014-12-31	$0
Total income from all sources (including contributions)	2014-12-31	$1,757,959
Total loss/gain on sale of assets	2014-12-31	$0
Total of all expenses incurred	2014-12-31	$485,693
Benefit payments and payments to participlants,beneficiaries,insurance carriers and others	2014-12-31	$468,110
Total contributions o plan (from employers,participants, others, non cash contrinutions)	2014-12-31	$1,383,911
Value of total assets at end of year	2014-12-31	$4,963,175
Value of total assets at beginning of year	2014-12-31	$3,690,909
Total of administrative expenses incurred including professional, contract, advisory and management fees	2014-12-31	$17,583
Total interest from all sources	2014-12-31	$392
Total dividends received (eg from common stock, registered investment company shares)	2014-12-31	$58,330
Has a resolution to terminate the plan been adopted during the plan year or any prior plan year	2014-12-31	No
Total dividends received from registered investment company shares (eg mutual funds)	2014-12-31	$58,330
Was this plan covered by a fidelity bond	2014-12-31	Yes
Value of fidelity bond cover	2014-12-31	$500,000
If this is an individual account plan, was there a blackout period	2014-12-31	Yes
Total value of distributions paid in property other than in cash, annuity contracts, or publicly traded employer securities	2014-12-31	$0
Were there any nonexempt tranactions with any party-in-interest	2014-12-31	No
Contributions received from participants	2014-12-31	$816,705
Participant contributions at end of year	2014-12-31	$14,738
Participant contributions at beginning of year	2014-12-31	$1,721
Income. Received or receivable in cash from other sources (including rollovers)	2014-12-31	$240,373
Did the receive any noncash contributions whose value was neither redily determinable on an established market nor set by an independent third party appraiser	2014-12-31	No
Value of net income/loss	2014-12-31	$1,272,266
Value of net assets at end of year (total assets less liabilities)	2014-12-31	$4,963,175
Value of net assets at beginning of year (total assets less liabilities)	2014-12-31	$3,690,909
Did the plan have a loss casued by fraud or dishonesty (regardless whether reimbursed by fidelity bond)	2014-12-31	No
Were any loans by the plan or fixed income obligations due to the plan in default	2014-12-31	No
Were any leases to which the plan was party in default or uncollectible	2014-12-31	No
Investment advisory and management fees	2014-12-31	$10,813
Value of interest in registered invesment companies (eg mutual funds) at end of year	2014-12-31	$4,945,062
Value of interest in registered invesment companies (eg mutual funds) at beginning of year	2014-12-31	$3,689,188
Interest on participant loans	2014-12-31	$392
Value of interest bearing cash (including money market accounts and certificates of deposits) at end of year	2014-12-31	$3,375
Net investment gain/loss from registered investment companies (e.g. mutual funds)	2014-12-31	$315,326
Were any plan transactions or series of transactions in excess of 5% of the current value of the plan assets	2014-12-31	No
Was there a failure to transmit to the plan any participant contributions	2014-12-31	No
Has the plan failed to provide any benefit when due under the plan	2014-12-31	No
Contributions received in cash from employer	2014-12-31	$326,833
Benefit payments and payments to provide benefits directly to participlants or beneficiaries including direct rollovers	2014-12-31	$468,110
Contract administrator fees	2014-12-31	$6,770
Was the provided the required notice or one of the exceptions to providing the black out period notice applied under 29 CFR 2520.101-3	2014-12-31	Yes
Did the plan have assets held for investment	2014-12-31	Yes
Did the plan hold any assets whose current value was neither redily determinable on an established market nor set by an independent third party appraiser	2014-12-31	No
Were all the plan assets eitehr distributed to particpants/beneficiaries, transferred to another plan or brought under the control of the PBGC	2014-12-31	No
Accountant perfomed limited scope audit pursuant to 29 CFR 2520.103-8 and/or 103-12(d)	2014-12-31	No
Opinion of an independent qualified public accountant for this plan	2014-12-31	Unqualified
Accountancy firm name	2014-12-31	BROWN,EDWARDS & COMPANY, LLP
Accountancy firm EIN	2014-12-31	540504608
2009 : UNIVERSITY PHARMACEUTICALS OF M.D. 401(K) PLAN 2009 401k financial data
Total value of distributions paid in property other than in cash, annuity contracts, or publicly traded employer securities	2009-12-31	$0

Form 5500 Responses for UNIVERSITY PHARMACEUTICALS OF M.D. 401(K) PLAN

2022: UNIVERSITY PHARMACEUTICALS OF M.D. 401(K) PLAN 2022 form 5500 responses
2022-01-01	Type of plan entity	Single employer plan
2022-01-01	Submission has been amended	No
2022-01-01	This submission is the final filing	No
2022-01-01	This return/report is a short plan year return/report (less than 12 months)	No
2022-01-01	Plan is a collectively bargained plan	No
2022-01-01	Plan funding arrangement – Trust	Yes
2022-01-01	Plan benefit arrangement - Trust	Yes
2021: UNIVERSITY PHARMACEUTICALS OF M.D. 401(K) PLAN 2021 form 5500 responses
2021-01-01	Type of plan entity	Single employer plan
2021-01-01	Submission has been amended	No
2021-01-01	This submission is the final filing	No
2021-01-01	This return/report is a short plan year return/report (less than 12 months)	No
2021-01-01	Plan is a collectively bargained plan	No
2021-01-01	Plan funding arrangement – Trust	Yes
2021-01-01	Plan benefit arrangement - Trust	Yes
2020: UNIVERSITY PHARMACEUTICALS OF M.D. 401(K) PLAN 2020 form 5500 responses
2020-01-01	Type of plan entity	Single employer plan
2020-01-01	Submission has been amended	No
2020-01-01	This submission is the final filing	No
2020-01-01	This return/report is a short plan year return/report (less than 12 months)	No
2020-01-01	Plan is a collectively bargained plan	No
2020-01-01	Plan funding arrangement – Trust	Yes
2020-01-01	Plan benefit arrangement - Trust	Yes
2019: UNIVERSITY PHARMACEUTICALS OF M.D. 401(K) PLAN 2019 form 5500 responses
2019-01-01	Type of plan entity	Single employer plan
2019-01-01	Submission has been amended	Yes
2019-01-01	This submission is the final filing	No
2019-01-01	This return/report is a short plan year return/report (less than 12 months)	No
2019-01-01	Plan is a collectively bargained plan	No
2019-01-01	Plan funding arrangement – Trust	Yes
2019-01-01	Plan benefit arrangement - Trust	Yes
2018: UNIVERSITY PHARMACEUTICALS OF M.D. 401(K) PLAN 2018 form 5500 responses
2018-01-01	Type of plan entity	Single employer plan
2018-01-01	Submission has been amended	No
2018-01-01	This submission is the final filing	No
2018-01-01	This return/report is a short plan year return/report (less than 12 months)	No
2018-01-01	Plan is a collectively bargained plan	No
2018-01-01	Plan funding arrangement – Trust	Yes
2018-01-01	Plan benefit arrangement - Trust	Yes
2017: UNIVERSITY PHARMACEUTICALS OF M.D. 401(K) PLAN 2017 form 5500 responses
2017-01-01	Type of plan entity	Single employer plan
2017-01-01	Submission has been amended	No
2017-01-01	This submission is the final filing	No
2017-01-01	This return/report is a short plan year return/report (less than 12 months)	No
2017-01-01	Plan is a collectively bargained plan	No
2017-01-01	Plan funding arrangement – Trust	Yes
2017-01-01	Plan benefit arrangement - Trust	Yes
2016: UNIVERSITY PHARMACEUTICALS OF M.D. 401(K) PLAN 2016 form 5500 responses
2016-01-01	Type of plan entity	Single employer plan
2016-01-01	Submission has been amended	No
2016-01-01	This submission is the final filing	No
2016-01-01	This return/report is a short plan year return/report (less than 12 months)	No
2016-01-01	Plan is a collectively bargained plan	Yes
2016-01-01	Plan funding arrangement – Trust	Yes
2016-01-01	Plan benefit arrangement - Trust	Yes
2015: UNIVERSITY PHARMACEUTICALS OF M.D. 401(K) PLAN 2015 form 5500 responses
2015-01-01	Type of plan entity	Single employer plan
2015-01-01	Submission has been amended	Yes
2015-01-01	This submission is the final filing	No
2015-01-01	This return/report is a short plan year return/report (less than 12 months)	No
2015-01-01	Plan is a collectively bargained plan	Yes
2015-01-01	Plan funding arrangement – Trust	Yes
2015-01-01	Plan benefit arrangement - Trust	Yes
2014: UNIVERSITY PHARMACEUTICALS OF M.D. 401(K) PLAN 2014 form 5500 responses
2014-01-01	Type of plan entity	Single employer plan
2014-01-01	Submission has been amended	No
2014-01-01	This submission is the final filing	No
2014-01-01	This return/report is a short plan year return/report (less than 12 months)	No
2014-01-01	Plan is a collectively bargained plan	Yes
2014-01-01	Plan funding arrangement – Trust	Yes
2014-01-01	Plan benefit arrangement - Trust	Yes
2009: UNIVERSITY PHARMACEUTICALS OF M.D. 401(K) PLAN 2009 form 5500 responses
2009-01-01	Type of plan entity	Single employer plan
2009-01-01	Submission has been amended	No
2009-01-01	This submission is the final filing	No
2009-01-01	This return/report is a short plan year return/report (less than 12 months)	No
2009-01-01	Plan is a collectively bargained plan	No
2009-01-01	Plan funding arrangement – Trust	Yes
2009-01-01	Plan benefit arrangement - Trust	Yes

Was this data useful?

If you found the data here useful, PLEASE HELP US. We are a start-up and believe in making information freely available. By linking to us, posting on twitter, facebook and linkedin about us and generally spreading the word, you'll help us to grow. Our vision is to provide high quality data about the activities of all the companies in the world and where possible make it free to use and view. Finding and integrating data from thousands of data sources is time consuming and needs lots of effort. By simply spreading the word about us, you will help us. Please use the share buttons. It will only take a few seconds of your time. Thanks for helping

Information Disclaimer

The information provided on this website is not advice, endorsement or recommendation
The information published is supplied by third parties so we make no warranty on the accuracy, completeness etc. This information is provided "as-is". The information is subject to change as we obtain updates and corrections from the primary information sources.
You are free to use the information for your own personal research on the understanding to do so is at your own risk.

See full terms and conditions

Company Name:	GREGORY PHARMACEUTICAL HOLDINGS, INC
Employer identification number (EIN):	522043017
NAIC Classification:	541700